FIELD: organic chemistry, biochemistry. SUBSTANCE: invention describes an inhibitor of testosterone 5α-reductase of the molecular formula (I) 5α where dotted line means optional pi-bond; 5α means hydrogen atom or methyl-group but if the indicated optional bond is absent then it does not mean hydrogen atom; means hydrogen atom; R4 means hydrogen atom; R6 means hydrogen atom or lower alkyl and R7 means R17α-alkyl or aryl tertiary amino-group or R17β-alkyl or aryl amido-group. New compounds can be used for treatment of patients with androgen-sensitive diseases course of that can be delayed by inhibition of androgenic receptors activation. Invention describes also a composition based on compounds of the formula (I) and a method of inhibition of activity of testosterone C1-C7-reductase. EFFECT: valuable curative properties of compounds. 8 cl, 8 dwg, 8 tbl, 19 ex
Title |
Year |
Author |
Number |
ANTIANDROGENIC COMPOUNDS, PRECURSOR OF ANTIANDROGENIC COMPOUND, PHARMACEUTICAL COMPOSITIONS |
1993 |
- Fernand Labri
- Iv Merand
- Shankar M.Singkh
|
RU2141966C1 |
BENZOPIPERIDINE DERIVATIVES, BICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON SAID |
1992 |
|
RU2142945C1 |
FLUORINATED DERIVATIVES OF 17β-SUBSTITUTED-4-AZA--5α-ANDROSTANE- -3-ONE, PHARMACEUTICAL COMPOSITION |
1993 |
- Akille Pantseri
- Marchella Nesi
- Ehnriko Di Salle
|
RU2125061C1 |
INDOLIZINE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF ACTIVITY OF TESTOSTERONE-5α-REDUCTASE |
1992 |
- Satosi Okada
- Kozo Savada
- Akio Kuroda
- Sinija Vatanabe
- Khirokazu Tanaka
|
RU2120942C1 |
16-SUBSTITUTED 4-AZAANDROSTANES, COMPOUNDS, METHODS OF INHIBITION, PHARMACEUTICAL COMPOSITION |
1994 |
- Filippe L.D'Jurette
- Uil'Jam K.Khagmann
- Tomas Dzh.Lantsa
- Soumia P.Sakhoo
- Gari Kh.Rasmusson
- Richard L.Tolman
- Derek Von Langen
|
RU2142956C1 |
METHOD OF TREATMENT OF PATIENTS WITH PROSTATE BENIGNITY HYPERPLASIA, PHARMACEUTICAL PREPARATION CONTAINING INHIBITOR OF 5-ALPHA-REDUCTASE |
1992 |
- Glenn Dzh.Gomlej
- Ehlizabet Stoner
|
RU2125879C1 |
17$$$-SUBSTITUTED 3-CARBOXYSTEROIDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION |
1992 |
- Akille Pantseri[It]
- Marchella Nesi[It]
- Ehnriko Di Salle[It]
|
RU2104283C1 |
17-HALOGEN-4-AZAANDROSTENE DERIVATIVES AND METHOD OF PREPARATION THEREOF |
1993 |
- Tuba Zoltan[Hu]
- Selesh Janosh[Hu]
- Balog Gabor[Hu]
- Khorvat Judit[Hu]
- Lovashne Marshai Marija[Hu]
|
RU2103275C1 |
METHOD OF PREPARING 7β--SUBSTITUTED 4-AZA -5α- ANDROSTAN- 3-ONES AND METHOD OF PREPARING SUBSTITUTED 7β- ALKYL ANDROST-5-EN-3-ONES |
1993 |
- Raman K.Bakshi
- Gari Kh.Rasmusson
|
RU2114117C1 |
ANDROSTEN(ANE) (ONE) DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SOLVATE THEREOF, METHODS OF PREPARATION THEREOF, AND METHOD OF MEDICAL TREATMENT |
1994 |
- Behchelor Kennet Uil'Jam
- Fraj Stiven Vernon
|
RU2144037C1 |